Butternut (Juglans cinerea L.): A Comprehensive Reference
1. Identity and Botanical Description
Nomenclature and Taxonomy
Butternut (Juglans cinerea L.) is a deciduous, nut-producing tree of the walnut family, Juglandaceae, native to eastern North America. It is also commonly known as white walnut and, less frequently, as lemon walnut or oil nut. Butternut belongs to the walnut family (Juglandaceae), which includes other nut trees such as pecan (Carya illinoinensis) and black walnut (Juglans nigra).
Juglans cinerea, commonly known as butternut or white walnut, is a species of walnut native to the eastern United States and southeast Canada. J. cinerea is a deciduous tree growing to 30 metres (98 ft) tall, rarely more. Butternut is a slow-growing species, and rarely lives longer than 75 years. It has a 40–80 cm (16–31 in) stem diameter, with light gray bark.
Morphology
A mature butternut tree has deeply furrowed gray bark and is about 15 to 18 metres (50 to 60 feet) tall with a trunk 30 to 60 cm (12 to 24 inches) in diameter. Each compound leaf, about 45 to 75 cm (18 to 30 inches) long, has 11 to 17 yellowish green leaflets that are hairy underneath. Chocolate-coloured partitions divide the pith of the twigs into many chambers. The egg-shaped fruit is a drupe and has a sticky greenish brown husk. The hard woody pit, which is not a true nut, bears many ridges and contains a sweet oily seed.
Yellowish green monoecious flowers appear in late spring (May–June), the male flowers in drooping catkins and the female flowers in short terminal spikes. Female flowers give way to clusters of edible oval nuts encased in hairy indehiscent husks. Nuts mature in fall. The name "butternut" comes from the mellow flavor of the nut.
Native Range and Habitat
Butternut is native to moist bottomlands, lowland forests and some drier limestone soils in eastern and midwestern North America, from New Brunswick to Minnesota, south to Georgia and Arkansas. Native to eastern North America, the butternut tree is found from southern Quebec and Ontario in Canada, down through much of the eastern and central United States. In the U.S., it naturally occurs from Minnesota, Wisconsin, and Michigan in the north, eastward through Pennsylvania, New York, and all of New England, and south through the Appalachian Mountains, including Ohio, West Virginia, Kentucky, Tennessee, and western parts of North Carolina and Georgia.
Medicinal and Supplemental Parts Used
The primary parts of the plant used in herbal medicine and as a dietary supplement are:
- Inner bark of the root and trunk — the principal part employed therapeutically, especially for its laxative and anthelmintic effects.
- Nut kernels — consumed as food and used to produce oil.
- Fruit husks (hull) — employed as a dye and as a source of juglone.
- Leaves — used in some traditional preparations.
The inner bark is the part most used in herbal medicine.
2. Conservation Status
The species is currently listed as Endangered on the IUCN Red List due to decline from an invasive fungus known as Ophiognomonia clavigignenti-juglandacearum (Oc-j) that causes butternut canker. Oc-j creates visible sores on the trunks of the tree, which essentially starves and slowly kills the tree. Natural resistance to this pathogen is rare.
The disease had already killed more than 80% of butternut trees in numerous states by the 1990s and is threatening the species with extinction. Diseased trees typically die within 5 to 10 years, and little resistance has been identified outside of hybrids with the introduced Japanese walnut (Juglans ailantifolia Carrière).
The species is not listed as threatened federally in the US, but is listed as rare (S3, meaning there are 21–100 individuals) in Tennessee, "Special Concern" in Kentucky, "Exploitably Vulnerable" in New York State, and "Endangered" in Illinois and Minnesota. The Committee on the Status of Endangered Wildlife in Canada placed the butternut on the endangered species list in Canada in 2005. The U.S. Forest Service has placed a moratorium on cutting healthy butternut trees in National Forests as of March 1993.
A number of measures are underway to halt extinction, including locating resistant butternut, collecting seed for germplasm, and hybridizing with the Japanese walnut (Juglans ailantifolia). The precarious conservation status of butternut has direct implications for the sustainability of wild-harvested bark, and this factor must be considered by any commercial or personal harvesting practice.
3. Traditional and Historical Uses
Indigenous North American Uses
Butternut was used by various Native North American Indian tribes as a laxative and tonic remedy to treat a variety of conditions including rheumatic and arthritic joints, headaches, dysentery, constipation, and wounds. Native Americans used the nuts for food and boiled the tree sap for syrup. They also used nuts to make oil for anointing.
Native American peoples used the fruits and bark as a dye, and this tradition was continued by European settlers. Multiple plant parts served distinct purposes: bark decoctions and root bark preparations addressed gastrointestinal complaints, while the hulls of unripe nuts served as vermifuges and dyestuffs.
Early settlers used fruit husks and inner bark to make orange or yellow dye and root bark for a laxative. The outer bark was used to make teas to treat dysentery and toothaches.
Traditional Preparations
The principal traditional preparations included decoctions and teas made from the inner root or stem bark, oil pressed or boiled from the nuts, and the use of unripe husks as a topical antimicrobial agent and systemic vermifuge. Traditional properties attributed to the plant included anthelmintic, cathartic, and tonic actions from the fruit; the leaves were considered alterative; the bark, laxative; and husks of the nuts, vermifuge.
The unripe, half-formed fruits were reportedly made into pickles. The sap was used to make a sugar, and the leaves, bark, and unripe fruit were used to make a dye that was chocolate-brown. Yellow to brown butternut colours were characteristic of some Confederate uniforms during the American Civil War, giving rise to southern soldiers being nicknamed 'butternuts.'
Use in Early American and Eclectic Medicine
Eclectic physicians of the nineteenth century — a North American school of medicine that integrated botanical remedies — employed butternut bark extensively as a gentle cathartic and biliary stimulant. It was distinguished from harsher cathartics (such as Cascara sagrada) by its reportedly non-cramping action. In modern herbalism it is considered to be a valuable remedy for chronic constipation, gently encouraging regular bowel movements, and is especially beneficial when combined with a carminative herb such as Angelica archangelica.
Culinary and Non-Medicinal Traditional Uses
The seed is eaten raw or ground into a powder and used with cereal flours in making cakes, biscuits, muffins, and bread. Baking and confectionery — especially the New England delicacy maple-butternut candy — are major culinary uses; young fruits can also be pickled.
4. Key Constituents and Active Compounds
Juglone (5-Hydroxy-1,4-naphthoquinone)
The most pharmacologically significant and extensively studied compound associated with butternut is juglone. Juglone (5-hydroxy-1,4-naphthoquinone) is found in the fresh ripe fruit husk, roots, leaves, and bark of walnut trees. Juglone is produced by numerous species of walnut tree, including Juglans nigra (black walnut), Juglans regia (English or Persian walnut), Juglans sieboldiana (Japanese walnut), and Juglans cinerea (butternut or white walnut).
It was not until the 1850s that juglone (then termed "nucin" from the Latin nux, meaning a nut) was first isolated from the walnut tree, and in 1881 the first scientific report on the allelopathic effect of juglone was published. Most studies refer to the use of Juglans nigra for isolation of juglone and allelopathic studies because this particular species produces the largest amount of juglone. Research on juglone's biological activities derived from other Juglans species, including J. cinerea, is considerably less extensive, and many pharmacological findings are extrapolated from studies on black walnut or isolated juglone.
Tannins
The constituents of walnut leaves are represented by tannins, phenolics, and naphthoquinones, the characteristic compound being juglone. The tannin content of butternut bark is responsible for its astringent properties, which historically justified its use in treating dysentery and diarrhea alongside its better-known cathartic role.
Fatty Acids and Nut Oil Composition
The nuts are a source of healthy fatty acids, such as linoleic acid. The nuts have long been recognised as highly oily; they are very oily, with a mild, buttery flavour. Native Americans exploited this oil content directly, boiling the nuts to extract oil for culinary and ceremonial use.
Other Phytochemicals
Walnut preparations are used in traditional medicine for the treatment of many health problems such as fungal, bacterial, viral, and helminthic infections, hypotension, hypoglycaemia, and even cancer. The relevant phytochemical classes present in the genus Juglans, including in J. cinerea, span:
- Naphthoquinones: Principally juglone (5-hydroxy-1,4-naphthoquinone); in plant tissues, juglone exists in a glycosylated, non-toxic precursor form.
- Hydrolyzable tannins: Responsible for astringency in bark preparations.
- Phenolic acids and flavonoids: Present in leaves and bark, contributing to antioxidant activity.
- Essential oils: Present in leaves and bark in small quantities.
- Unsaturated fatty acids: Including linoleic acid, found in nut kernels.
5. Mechanisms of Action
Laxative / Cathartic Mechanism
The laxative effect of butternut bark is attributed to its naphthoquinone and tannin content, which collectively stimulate bowel motility and act on the bile pathway. In modern herbalism, butternut is considered a valuable remedy for chronic constipation, gently encouraging regular bowel movements. The bark produces a soothing, tonic laxative action that is particularly suited to chronic constipation. Unlike anthranoid-containing laxatives (e.g., senna, cascara), the mechanism in butternut does not depend on anthraquinone stimulation of the colon, which likely explains the reportedly gentler character of its cathartic effect. No controlled mechanistic studies specific to J. cinerea bark in human tissue have been published in the peer-reviewed literature.
Juglone: Redox and Cytotoxic Mechanisms
Juglone (5-hydroxy-1,4-naphthoquinone), a phenolic compound found in walnuts, has been extensively studied not only for its redox properties but also for its antimicrobial properties and its implication in anticancer activity through the signaling pathway and reactive oxygen species (ROS) production.
The cytotoxic properties of naphthoquinones, like juglone, involve the induction of oxidative stress with redox cycling, cell membrane damage, apoptosis, and necrotic cell death. Naphthoquinone compounds, like juglone, can inhibit oxidant reactions by quenching ROS, inhibiting ROS-producing enzymes, and chelating transition metal ions (like Fe²⁺) by a hydrogen atom transfer mechanism.
The dual nature of juglone's redox behavior is key to understanding both its potential therapeutic uses and its toxicity. Like other quinones, the cytotoxicity of juglone includes redox cycling and reaction with glutathione (GSH), an endogenous antioxidant. Juglone's action in cancer cells specifically involves the mitochondrial apoptotic pathway: recent studies showed that juglone is a potent cytotoxic agent and induces cell apoptosis through the mitochondria-dependent pathway in human cancer cell lines such as human lung cancer (A549) cells, human leukemia (HL-60) cells, and human cervical carcinoma (HeLa) cells.
In terms of its toxicity mechanisms, a number of studies have established that juglone causes cell death, disrupts the cell cycle, modifies DNA (especially in rapidly dividing cells), inhibits mRNA synthesis, alkylates basic protein thiol or amine groups, and reduces tumour suppressor levels.
In living plants, juglone is in a non-toxic glycosylated form, but when exposed to soil or air, this allelochemical compound is immediately transformed into an oxidized and highly toxic form.
Antifungal and Antimicrobial Mechanism
Traditionally, the antimicrobial properties of juglone have been exploited in folk medicine. For example, the juice obtained from freshly macerated, unripe black walnut (Juglans nigra) shells has been used for the treatment of local fungal infections, reflecting the presence of bioactive naphthoquinones in plant tissues. Experimental studies have confirmed the antifungal efficacy of juglone and walnut-derived extracts against a broad spectrum of pathogens, including plant pathogens (such as Alternaria alternata, Rhizoctonia solani, Botrytis cinerea, Fusarium culmorum, Phytophthora infestans), bee pathogens (Ascosphaera apis), and food-contaminating fungi.
6. Scientific Evidence by Area of Use
Note: The overwhelming majority of available research on butternut's biologically active compound, juglone, derives from in vitro (cell culture) and animal model studies. No rigorously controlled randomized clinical trials (RCTs) specifically on Juglans cinerea preparations in human subjects were identified in the peer-reviewed literature. Findings summarized below reflect the current state of the preclinical science and must be clearly distinguished from established clinical evidence.
6.1 Gastrointestinal System: Laxative and Cholagogue Effects
The use of butternut inner bark as a mild laxative and bile-stimulating (cholagogue) agent is well-documented in ethnobotanical and historical herbal literature but has not been evaluated in published human clinical trials. Butternut produces a soothing, tonic laxative action particularly suited to chronic constipation. Herbalists use the inner bark as a gentle laxative; butternut bark may be taken as a tea or powdered and put in capsules.
Evidence strength: Traditional use only; no controlled human trial data identified.
6.2 Antimicrobial Activity
The antimicrobial potential of butternut-derived juglone has been examined in multiple laboratory studies. Despite its evidenced beneficial herbicidal, antibacterial, antiviral, antifungal, and antioxidant effects, the application of juglone (5-hydroxy-1,4-naphthoquinone) is limited due to its low water solubility and allelopathic and toxic effects.
In some cases, the antifungal effectiveness of juglone has been reported to be comparable with selected commercially used agents such as zinc undecylenate and selenium sulfide. These comparisons were made in vitro, not in clinical settings. In recent years, research has aimed to overcome juglone's limitations by increasing its solubility and controlling its release through nanoparticular systems.
Evidence strength: Preclinical in vitro only; no human clinical trials identified specifically for J. cinerea. Antimicrobial findings for juglone are broadly replicated across laboratory studies but not translated to human trial evidence.
6.3 Anticancer / Cytotoxic Activity
Juglone has been studied as a candidate anticancer compound across numerous in vitro systems. Juglone has been investigated as a potential anticancer agent against breast cancer, lung cancer, prostate cancer, colorectal cancer, melanoma, and glioma.
In one published study specifically examining ovarian cancer, the juglone-induced antitumor effect was evaluated in ovarian cancer SKOV3 cells. MTT assay was performed to examine juglone's anti-proliferative effect. Cell cycle and apoptosis were studied using flow cytometry in juglone-treated SKOV3 cells. Protein expression levels were measured by Western blot analysis of cyclin D1, Bcl-2, Bax, cytochrome c, caspase-9, and caspase-3. A Matrigel invasion assay was employed to characterize cell invasion. Juglone significantly inhibited SKOV3 cell proliferation as shown by G0/G1 phase arrest, and this effect was mediated by inactivation of cyclin D1 protein (P<0.05).
The multidrug resistance developed by the doxorubicin-resistant HL-60 cell line did not prevent the cytotoxic effect of juglone. Juglone also exhibited cytotoxicity to human hepatoma cell line HepG2 and the BALB/c mouse fibroblast cell line 3T3.
Despite this body of in vitro work, according to current study progress on juglone, it is still lacking in clinical applications. Previous studies showed that, from the perspective of possible clinical translation, the cytotoxic activity of juglone against MCF-7 cells is even better than tamoxifen, the gold standard drug for ER+ breast cancer treatment, but a detailed description of its anticancer potential has been hampered by the absence of clinical studies.
Evidence strength: Preclinical (in vitro and some animal models) only. No human clinical trials have been conducted. Translation to clinical utility remains entirely unproven.
6.4 Antioxidant Activity
Juglone and other polyphenolic compounds in butternut demonstrate dual oxidant/antioxidant behavior depending on concentration and cellular environment. Naphthoquinone compounds like juglone can inhibit oxidant reactions by quenching ROS, inhibiting ROS-producing enzymes, and chelating transition metal ions (like Fe²⁺) by a hydrogen atom transfer mechanism. One animal study examined juglone's protective effects against heavy-metal-induced organ damage: the aim was to evaluate the possible effects of iron and zinc on kidney and liver tissues and the positive effects of juglone antioxidant activity, using an immunohistochemical technique; animals were divided into five groups including iron-, zinc-, iron + juglone-, and zinc + juglone-treated groups.
Evidence strength: In vitro and animal studies only. No clinical evidence for antioxidant benefit in humans.
6.5 Antiparasitic / Anthelmintic Activity
Butternut bark and husks have a long recorded history of use against intestinal worms and parasites across multiple indigenous cultures. The bark or the unripe nut was reportedly used to expel worms and parasites, and was also used for feverish colds and flu. Walnut preparations are used in traditional medicine for the treatment of helminthic infections, among other conditions.
The anthelmintic mechanism is thought to involve juglone's reactivity against the electron transport chains of parasitic organisms, though direct mechanistic evidence specific to J. cinerea in clinical settings is absent from the literature.
Evidence strength: Traditional use, supported by theoretical mechanistic plausibility from juglone research; no controlled clinical evidence.
6.6 Anti-inflammatory and Analgesic Effects
Butternut was used by various Native North American Indian tribes as a laxative and tonic remedy to treat rheumatic and arthritic joints, headaches, dysentery, constipation, and wounds. No peer-reviewed human clinical study specifically examining butternut preparations for inflammatory conditions was identified.
Evidence strength: Traditional use only; no clinical evidence.
7. Dosage Forms and Reported Dosages
Traditional Forms
Butternut is prepared and consumed in several traditional forms:
- Bark decoction (tea): Inner root bark or stem bark simmered in water. One herbal reference reports a decoction prepared using ½–1 teaspoon of the root bark or hulls (or 1 teaspoon of the leaves) per cup of water.
- Liquid extract / tincture: A 1:5 dry liquid extract has been cited at a dose of 1–10 drops, 1–3 times per day in a little water.
- Powdered bark capsules: Butternut bark may be powdered and put in capsules.
- Chopped bark tincture: Chopped bark can be tinctured.
Notes on Dosage
Butternut preparations are generally noted as not intended for long-term use. No standardized, clinically validated dosage for any Juglans cinerea preparation has been established in the peer-reviewed literature. Dosages cited in herbal practice manuals are empirical, based on historical tradition rather than dose-finding clinical studies. The absence of clinical pharmacokinetic data for juglone from butternut specifically — as distinct from other Juglans species — means that safe and effective dose ranges remain formally undefined.
One study on Juglans regia leaves found that the content of juglone in a methanolic extract was 9.9 ± 0.2 mg/100 g, while small amounts (1.3 ± 0.02 mg/100 g) were recorded in an infusion, and in a decoction it was not detected. As some studies indicate toxicity of juglone, only decoctions were suggested for therapeutic use — a finding potentially relevant to butternut preparations as well.
8. Body Systems and Health Areas of Association
- Gastrointestinal tract: Laxative, cholagogue, antidysenteric, anthelmintic.
- Immune system / Infection: Antimicrobial (antibacterial, antifungal, antiviral) attributed to juglone content.
- Oncology (preclinical): Cytotoxic and anti-proliferative effects on cancer cell lines studied in vitro.
- Musculoskeletal system: Historically used for rheumatic and arthritic complaints.
- Integument (skin): Astringent bark preparations applied to wounds; husks used as a topical agent.
- Liver (hepatic): Classified as a cholagogue/hepatic herb in traditional systems; juglone has also demonstrated hepatotoxic potential at higher doses in animal models.
9. Safety Considerations and Drug Interactions
Juglone Toxicity
Juglone (5NQ) is a bioactive molecule found in walnuts and has shown therapeutic effects in various disease models; however, limited information is available regarding its toxicity, thereby limiting clinical development. In a mouse oral toxicity study, oral acute (50, 300, and 2000 mg/kg) and sub-acute toxicity (5, 15, and 50 mg/kg) were assessed. The acute toxicity study identified 118 mg/kg as the point-of-departure dose for single oral administration. Repeated administration at 15 and 50 mg/kg/day caused reduction in food consumption and body weight, along with alterations in liver and renal function. Histopathological assessment revealed significant damage to hepatic and renal tissues at all doses in the acute study, and at higher doses in the sub-acute study.
Juglone causes toxicosis in fish and laboratory animals. Juglone was demonstrated to cause blockage of oxidative phosphorylation in corn and fish cell mitochondria. The relevance of animal toxicity findings to human consumption of dilute butternut bark preparations is uncertain, but the data indicate that juglone is not a benign compound at elevated systemic doses.
Mutagenic Potential
One study synthesized juglone-loaded polymeric nanoparticles and compared them with free juglone for cytotoxicity and mutagenic potential in Salmonella typhimurium TA98/100. Mouse and plant cells treated with free and nano-encapsulated juglone showed a decrease in cell viability in a dose and time-dependent manner. The mutagenic activity of juglone in the Ames test has been explored; results suggest concentration-dependent genotoxicity, underscoring the complexity of its safety profile.
Preparation-Dependent Juglone Content
Research on Juglans regia leaves found that juglone content in a methanolic extract was 9.9 ± 0.2 mg/100 g, with small amounts (1.3 ± 0.02 mg/100 g) in an infusion, while in a decoction it was not detected. As some studies indicate toxicity of juglone, only decoctions should be recommended for therapeutic use. This finding implies that the preparation method meaningfully affects the juglone content delivered to the consumer.
Gallstone Caution
Butternut preparations are contraindicated in individuals with gallstones. The cholagogue (bile-stimulating) activity of butternut bark could potentially aggravate biliary colic or complications in persons with cholelithiasis.
Pregnancy
Herbalists and supplement manufacturers note avoidance during pregnancy on the basis of the plant's cathartic activity. This caution appears consistently in traditional herbalism sources. No controlled human safety data in pregnancy are available.
Allelopathic Juglone in the Environment
Butternut roots produce chemicals called juglones which are very toxic to certain other plants such as azaleas, rhododendrons, blueberries, peonies, and solanaceous crops (tomatoes, peppers, and potatoes). The toxic zone extends 60 to 80 feet from the trunk of the tree. This allelopathic property is well established in horticultural and ecological contexts, though it is distinct from concerns about human consumption of bark or nut preparations.
Drug Interactions
No formally documented herb-drug interactions for butternut (Juglans cinerea) preparations have been identified in the peer-reviewed pharmacological literature. Juglone is a traditional drug with ambiguous health and toxic effects. The compound's known ability to interact with cellular redox systems and glutathione pathways raises a theoretical concern for additive oxidative stress in patients taking medications that are also redox-active or hepatotoxic, but this has not been formally studied.
Tree Nut Allergy Cross-Reactivity
Because butternut is a member of the same botanical family (Juglandaceae) and the same genus (Juglans) as the commercially common English walnut, cross-reactive allergenicity in persons with established tree-nut allergies — particularly walnut allergy — is a plausible safety concern, though species-specific allergy data for J. cinerea are limited in the published literature.
10. Summary of Evidence Status
Butternut (Juglans cinerea) occupies a well-documented position in indigenous North American ethnobotany as a laxative, anthelmintic, and cholagogue herb, with supporting use by European settlers and Eclectic physicians. Its primary bioactive constituent, juglone, has accumulated a substantial body of in vitro and animal-model research pointing to antimicrobial, cytotoxic, antioxidant, and anticancer properties. However, these preclinical findings have not been translated into controlled human clinical trials. A detailed description of juglone's anticancer potential has been hampered by the absence of clinical studies. No standardized dose has been validated in clinical research. The tree is critically threatened in the wild, which limits the sustainability of wildcrafted bark supply. The dual nature of juglone as both a bioactive and potentially hepatotoxic agent at higher doses demands caution in extrapolating preclinical findings to therapeutic recommendations.
References
Go back